Seed Therapeutics

Seed Therapeutics is a global research company focused on utilizing and engineering molecules to target proteins using "molecular glue" that were previously considered "undruggable." Seed Therapeutics is pioneering the science of improving human health by creating "molecular glues": novel therapies that degrade disease-causing proteins which have been "untreatable." Through ongoing collaboration with world-leading academic experts in this field, as well as experienced drug development and commercialization specialists, Seed Therapeutics is building an increasing number of exciting drug candidates on the path to clinical and commercial success. Our mission is to positively impact human health by creating new protein degradation therapies to treat serious diseases, where healthcare professionals currently have limited options for patients.